The product is good no doubt But does anyone else think that with out real news in the next little while the market will punish it somewhat because of the extra dilution, don't know wheather to buy more now at 13 or maybe get lucky at 10 or 11. It was a good percentage dilution about 30% that they gave us so logic says it will trend down, I will be the first to admit I was shocked it went up on Friday. I know there is the 25 cent thingy in there but normally this kind of dilution does not help out a junior, but obviously we have a product that many many people will use, how could they not. I want to add but my experience says down dip first, but that's assuming no real news in the next week or 2.
All this being said this stock as far as I'm concerned is the kind that could take off to 500% gains in the blink of an eye, it's the kind of product that the big boys don't need to wait and see if Pre-vu will be used but more how many people will use it. Doesn't need clinical trials, safe and easy to use and saves people time and health care systems money, it kind of sells itself.